文献速递母胎医学

英格兰国家产前外显子组测序服务的实施:成本-效果分析

Implementation of a National Prenatal Exome Sequencing Service in England: Cost-Effectiveness Analysis.
PubMed 文献 · BJOG · 2024-11-21

该成本-效果分析基于英格兰NHS基因组医学服务中413例疑似遗传病因的胎儿结构异常转诊家庭,评估产前外显子组测序(pES)联合标准检测相较单独标准检测的成本与效果。

要点

  • 413例转诊中241例接受检测,每例转诊增量成本2331英镑,每例检测增量成本3592英镑。
  • 诊断率35.3%,每增加一例诊断的增量成本为11326英镑。

核心结论

  • pES为英格兰NHS每增加一例诊断花费11326英镑,家庭增量成本可忽略不计。

研究设计与样本

  • 成本-效果分析,结合成本、结局、家长与专业人员访谈及专业人员调查数据。
  • 样本为2021年10月1日至2022年6月30日转诊pES的413例疑似遗传病因的胎儿异常家庭。

主要发现

  • 413例转诊中241例接受检测,每例转诊成本2331英镑(95%可信区间1894-2856),每例接受检测成本3592英镑(2959-4250)。
  • 诊断率35.3%,每增加一例诊断的增量成本为11326英镑(8582-15361)。
  • 家庭成本无法与其它妊娠相关预约分离,但不被认为构成负担,多数预约同时进行或远程进行。

局限性

  • 家庭成本无法与其它妊娠相关预约分离。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Prenatal exome sequencing (pES) for diagnosing fetal structural anomalies commenced in the English National Health Service (NHS) in 2020. We evaluated cost-effectiveness to the healthcare system, and costs to families, of pES in addition to standard testing, compared to standard testing alone. DESIGN: A cost-effectiveness analysis combining costs, outcomes, parent and professional interview and professional survey data. SETTING: The English NHS Genomic Medicine Service. SAMPLE: 413 families with fetal anomalies with a suspected genetic cause referred for pES from 01 October 2021 to 30 June 2022. METHODS: We costed the incremental resource required to deliver the pES clinical pathway. We calculated the diagnostic yield (proportion of cases with pathogenic variants). We divided the total incremental cost by the number of cases with a diagnosis to calculate cost-effectiveness. We estimated the annual NHS budget requirement based on case numbers. We determined parental costs from interviews. MAIN OUTCOME MEASURES: Incremental costs of pES to the NHS and families, incremental cost per additional diagnosis and NHS budget impact. RESULTS: Of 413 referred cases, 241 were tested, at a cost of £2331 (95% credibility interval £1894-£2856) per referred case or £3592 (£2959-£4250) per case that proceeded with testing. The incremental cost per diagnosis (yield 35.3%) was £11 326 (£8582-£15 361). Based on referrals data 01 October 2022 to 30 September 2023, pES costs the NHS £1.8 m annually. Family costs could not be separated from other pregnancy-related appointments but were not considered burdensome; most appointments were concurrent or remote. CONCLUSION: pES costs the English NHS £11 326 for each additional diagnosis. Incremental costs to families are negligible.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Smith EJ, Hill M, Peter M, et al. Implementation of a National Prenatal Exome Sequencing Service in England: Cost-Effectiveness Analysis. BJOG. 2024. PMID: 39572407. doi:10.1111/1471-0528.18020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。